GPR34 regulates microglia state and loss-of-function rescues TREM2 metabolic dysfunction
Raju, K.; Joy, D.; Guldberg, S. M.; Germain, K.; Gould, N.; Ha, C.; Tatarakis, D.; Dugas, J. C.; Davis, S.; Reeves, A.; Andrews, S. V.; Weerakkody, T.; Suh, J.; Lunkes de Melo, G.; Xiong, K.; Lightfoot, Y.; Propson, N.; Sandmann, T.; Di Paolo, G.; Lewcock, J. W.; Ray, W. J.; Monroe, K.
Show abstract
Microglia are implicated in modifying neurodegenerative disease risk in the central nervous system (CNS). GPR34 is a microglia-enriched G-protein coupled receptor that detects cytotoxic lipids upregulated in Alzheimers Disease (AD). Since dysregulated lipid metabolism occurs in disease, we hypothesized GPR34 could act with other lipid sensors, such as TREM2, to regulate microglial function. Here, we report that GPR34 knockout (KO) rescues dysregulated cholesterol metabolism in TREM2 KO iPSC-derived microglia (iMG) and alone promotes fatty acid catabolism without the proton leak observed in TREM2 KO. Loss of GPR34 downregulated ERK signaling, while its agonism promoted interaction with and activation of ERK. In healthy and amyloid mouse models, Gpr34 KO accelerated the conversion of homeostatic microglia to disease-associated microglia (DAM) states. Additionally, in Gpr34 KO amyloid mouse brain, the frequency of large plaques was increased compared to WT, indicating that Gpr34 KO microglia may promote amyloid aggregation. Overall, our data suggest GPR34 as a therapeutic target for modulating microglial function to slow AD progression.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Triglyceride metabolism controls inflammation and APOE4-associated disease states in microglia 97%
- Natural genetic variation determines microglia heterogeneity in wild-derived mouse models of Alzheimer's disease 96%
- Sustained TREM2 stabilization accelerates microglia heterogeneity and Abeta pathology in a mouse model of Alzheimer s disease 96%
Similar papers in this journal
- APOE4 Lowers Energy Expenditure and Impairs Glucose Oxidation by Increasing Flux through Aerobic Glycolysis 96%
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 96%
- DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity 96%
Similar papers in this journal
- Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy 97%
- Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina 96%
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 96%
Similar papers in this journal
- Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model 97%
- The Alzheimers Disease Risk Genes MS4A4A And MS4A6A Cooperate to Negatively Regulate Trem2 and Microglia states 96%
- A systems biology-based identification and in vivo functional screening of Alzheimer's disease risk genes reveals modulators of memory function 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.